Regenxbio (RGNX) Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Regenxbio Inc. (RGNX) PT Raised to $40 at Stifel
March 7, 2024 10:39 AM ESTStifel analyst Annabel Samimy raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $40.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy on RGNX and raise TP to $40 after another meaningful RGX-202 update from the AFFINITY-DUCHENNE Ph.1/2... More
